Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ASSURANCE: Stem Cell Injection in End-Stage Heart Failure Patients With LVAD
NCT00869024Phase 2Completed
- Sponsor
- University of Minnesota
- Start
- Nov 2011
- Primary completion
- Mar 2016
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of bone marrow mononuclear cells in heart failure (HF), sponsored by University of Minnesota. Started Nov 2011; status: completed.
02
Drugs
bone marrow mononuclear cells
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NCT00869024.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00869024.